Monaco Asset Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-243,642
Closed -$728K 68
2023
Q4
$728K Sell
243,642
-928,137
-79% -$1.2M 0.21% 60
2023
Q3
$1.15M Buy
1,171,779
+476,477
+69% +$689K 0.34% 46
2023
Q2
$966K Buy
695,302
+551,940
+385% +$771K 0.27% 48
2023
Q1
$228K Sell
143,362
-326,738
-70% -$1.69M 0.07% 62
2022
Q4
$2.93M Buy
470,100
+210,100
+81% +$1.5M 0.88% 32
2022
Q3
$1.74M Buy
260,000
+87,500
+51% +$601K 0.67% 30
2022
Q2
$1.1M Sell
172,500
-246,762
-59% -$1.4M 0.48% 39
2022
Q1
$1.95M Sell
419,262
-80,738
-16% -$346K 0.77% 24
2021
Q4
$2.5M Buy
+500,000
New +$4M 0.62% 22

Other funds holding ESPR